{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:20:01Z","timestamp":1787772001528,"version":"build-2784847793"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Due to heterogeneity of acute myeloid leukemia (AML) in prognosis and response to treatment, understanding the pathophysiology of AML helps to find new factors as diagnostic and clinicopathological-related biomarkers and therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Using quantitative real-time polymerase chain reaction on AML patients, the expression of the miR15a-5p, c-MYB, and circ-HIPK3 gene network was measured, and the diagnostic performance and clinical application value of this gene network were also investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In AML patients compared with healthy controls, the expression of mir-15a-5p and circ-HIPK3 significantly decreased, and the expression of c-MYB was significantly upregulated. Furthermore, c-MYB correlates with circ-HIPK3 positively. The areas under receiver operating characteristic curves (AUCs) of miR15a-5p, c-MYB, and circ-HIPK3 were 0.675, 0.885, and 0.762, respectively. Also, peripheral blood, as a noninvasive and cost-effective diagnostic sample, has good diagnostic value for the investigation of the mir15a-5p, c-MYB, and circ-HIPK3 genes. Finally, the change in circ-HIPK3 expression and red blood cell count showed a significant relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results can contribute to a better pathophysiology understanding of AML, lead to the discovery of new diagnostic biomarkers, and develop treatment goals for patients. Also, the relationship between the genes and the clinicopathological characteristics of the patients helps patient monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_252_24","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:00:26Z","timestamp":1753941626000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["MiR-15a-5p, c-MYB, and circHIPK3 Axis as a Potential Diagnostic and Clinicopathological-Related Network in Acute Myeloid Leukemia"],"prefix":"10.4103","volume":"14","author":[{"given":"Yasin","family":"Mirazimi","sequence":"first","affiliation":[{"name":"Student Research Committee, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Aghayan","sequence":"additional","affiliation":[{"name":"Student Research Committee, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Garavand","sequence":"additional","affiliation":[{"name":"Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Nasehi","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran"},{"name":"Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hajifathali","sequence":"additional","affiliation":[{"name":"Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rafiee","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran"},{"name":"Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1024\/0040-5930\/a001126","article-title":"[Diagnosis and Therapy of Acute Myeloid Leukemia]","volume":"76","author":"Medinger","year":"2019","journal-title":"Therapeutische Umschau Revue therapeutique"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","article-title":"Molecular biomarkers in acute myeloid leukemia","volume":"31","author":"Prada-Arismendy","year":"2017","journal-title":"Blood Rev"},{"key":"R3-20250731","first-page":"2577","article-title":"Hypomethylating agents for elderly patients with acute myeloid leukemia: A PRISMA systematic review and meta-analysis","volume":"25","author":"Zhang","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"Suppl 1","key":"R4-20250731","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ctrv.2011.04.013","article-title":"DNA methylation as a pathogenic event and as a therapeutic target in AML","volume":"37","author":"Schoofs","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"R5-20250731","first-page":"1","article-title":"Comparison of secreted frizzled-related protein -4 and -5 promoter methylation in patients with acute myeloblastic leukemia and healthy individuals","volume":"13","author":"Ghaffari","year":"2021","journal-title":"Iran J Blood Cancer"},{"key":"R6-20250731","first-page":"213","article-title":"Methylation status of SOX17 and RUNX3 genes in acute leukemia","volume":"7","author":"Ghasemi","year":"2015","journal-title":"Iran J Blood Cancer"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-021-01446-z","article-title":"Circular RNAs in acute myeloid leukemia","volume":"20","author":"Singh","year":"2021","journal-title":"Mol Cancer"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: Metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.csbj.2021.01.018","article-title":"Review on circular RNAs and new insights into their roles in cancer","volume":"19","author":"Tang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"R10-20250731","first-page":"727","article-title":"The research progress of circular RNAs in hematological malignancies","volume":"24","author":"Ji","year":"2019","journal-title":"Hematology (United Kingdom)"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12935-021-01956-2","article-title":"Biogenesis, cellular effects, and biomarker value of circHIPK3","volume":"21","author":"Fu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R12-20250731","first-page":"10","article-title":"Circular RNA HIPK3: A key circular RNA in a variety of human cancers","author":"Wen","year":"2020","journal-title":"Front Oncol"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"117252","DOI":"10.1016\/j.lfs.2019.117252","article-title":"The circular RNA HIPK3 (circHIPK3) and its regulation in cancer progression: Review","volume":"254","author":"Xie","year":"2020","journal-title":"Life Sci"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40778-016-0057-1","article-title":"MicroRNAs in control of stem cells in normal and malignant hematopoiesis","volume":"2","author":"Roden","year":"2016","journal-title":"Curr Stem Cell Rep"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.25056","article-title":"MicroRNA as biomarkers and diagnostics","volume":"231","author":"Wang","year":"2016","journal-title":"J Cell Physiol"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.biopha.2017.05.144","article-title":"Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia","volume":"92","author":"Braga","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1002\/jcp.27342","article-title":"The miR-15a\/16 gene cluster in human cancer: A systematic review","volume":"234","author":"Liu","year":"2019","journal-title":"J Cell Physiol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2012.225","article-title":"Role and potential for therapeutic targeting of MYB in leukemia","volume":"27","author":"Pattabiraman","year":"2013","journal-title":"Leukemia"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s12935-021-02362-4","article-title":"Intricate crosstalk between MYB and noncoding RNAs in cancer","volume":"21","author":"Hu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/leu.2013.23","article-title":"C\/EBP\u03b1 and MYB regulate FLT3 expression in AML","volume":"27","author":"Volpe","year":"2013","journal-title":"Leukemia"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrc2439","article-title":"MYB function in normal and cancer cells","volume":"8","author":"Ramsay","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood-2008-01-136218","article-title":"The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells","volume":"113","author":"Zhao","year":"2009","journal-title":"Blood"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1073\/pnas.1018384108","article-title":"MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13","volume":"108","author":"Sankaran","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4161\/cbt.7.11.6722","article-title":"c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster","volume":"7","author":"Chung","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"R25-20250731","first-page":"583","article-title":"MicroRNA expression in \u03b2-thalassemia and sickle cell disease: A role in the induction of fetal hemoglobin","volume":"17","author":"Saki","year":"2016","journal-title":"Cell J"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41419-018-0454-8","article-title":"CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7","volume":"9","author":"Zeng","year":"2018","journal-title":"Cell Death Dis"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCULATIONAHA.117.029004","article-title":"Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus","volume":"136","author":"Shan","year":"2017","journal-title":"Circulation"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12859-021-04306-1","article-title":"Web-based LinRegPCR: Application for the visualization and analysis of (RT)-qPCR amplification and melting data","volume":"22","author":"Untergasser","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12859-022-04705-y","article-title":"CircPrimer 2.0: A software for annotating circRNAs and predicting translation potential of circRNAs","volume":"23","author":"Zhong","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjh.12750","article-title":"Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use","volume":"165","author":"Liersch","year":"2014","journal-title":"Br J Haematol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"\u2018Acute myeloid leukemia: A comprehensive review and 2016 update\u2019","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fonc.2014.00055","article-title":"Molecular therapeutic approaches for pediatric acute myeloid leukemia","volume":"4","author":"Tasian","year":"2014","journal-title":"Front Oncol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"R36-20250731","first-page":"632","article-title":"Emerging treatments in acute myeloid leukemia: Current standards and unmet challenges","volume":"15","author":"Percival","year":"2017","journal-title":"Clin Adv Hematol Oncol"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bjh.16360","article-title":"The power and potential of integrated diagnostics in acute myeloid leukaemia","volume":"188","author":"Haferlach","year":"2020","journal-title":"Br J Haematol"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00277-014-2072-6","article-title":"Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: A systematic review and meta-analysis","volume":"93","author":"Port","year":"2014","journal-title":"Ann Hematol"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1158\/1078-0432.CCR-16-2628","article-title":"Correlation between isocitrate dehydrogenase gene aberrations and prognosis of patients with acute myeloid leukemia: A systematic review and meta-analysis","volume":"23","author":"Xu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"e23707","DOI":"10.1097\/MD.0000000000023707","article-title":"The incidence and prognostic effect of Fms-like tyrosine kinase 3 gene internal tandem and nucleolar phosphoprotein 1 genes in acute myeloid leukaemia: A PRISMA-compliant systematic review and meta-analysis","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine"},{"key":"R41-20250731","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13045-019-0734-5","article-title":"Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.22.01114","article-title":"Long Noncoding RNA expression independently predicts outcome in pediatric acute myeloid leukemia","volume":"41","author":"Farrar","year":"2023","journal-title":"J Clin Oncol"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/16078454.2020.1779480","article-title":"The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: A meta-analysis","volume":"25","author":"Shi","year":"2020","journal-title":"Hematology"},{"key":"R44-20250731","first-page":"69","article-title":"Statistics corner: A guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med J"},{"key":"R45-20250731","first-page":"31","article-title":"Diagnostic value of circular RNAs as promising hematological biomarkers in acute myeloid leukemia: A systematic review and meta-analysis","volume":"30","author":"Aghayan","year":"2025","journal-title":"J Res Med Sci"},{"key":"R46-20250731","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: A single indicator of test performance","volume":"56","author":"Glas","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R47-20250731","first-page":"203","article-title":"Measures of diagnostic accuracy: Basic definitions","volume":"19","author":"\u0160imundi\u0107","year":"2009","journal-title":"EJIFCC"},{"key":"R49-20250731","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.hoc.2009.11.008","article-title":"Acute myeloid leukemia","volume":"24","author":"Rubnitz","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"R50-20250731","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1080\/03610926.2015.1134575","article-title":"Relative effect sizes for measures of risk","volume":"46","author":"Olivier","year":"2017","journal-title":"COMMUN STAT-THEOR M"},{"key":"R51-20250731","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00277-025-06300-6","article-title":"Prognostic value of circular RNAs expression and their correlation with clinicopathological features in acute myeloid leukemia: a systematic review and meta-analysis","volume":"104","author":"Mirazimi","year":"2025","journal-title":"Ann Hematol"},{"key":"R52-20250731","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12935-023-03028-z","article-title":"CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; A systematic review and meta-analysis","volume":"23","author":"Mirazimi","year":"2023","journal-title":"Cancer Cell Int"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_252_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:24:12Z","timestamp":1787768652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_252_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_252_24","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-05-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}